Meibomian Blepharitis drugs in development, 2023

GlobalData tracks 5 drugs in development for Meibomian Blepharitis by six companies/universities/institutes. The top development phase for Meibomian Blepharitis is phase ii, with three drugs in that stage.

Opinion | How to Spot Anti-Abortion ‘Crisis Pregnancy’ Centers

I had just finished presenting my ob/gyn chief Grand Rounds on adolescent pregnancy when I saw a raised hand from an audience participant. “You know

May 3, 2023

Exploring the health benefits and production challenges of alternative proteins

Researchers review the health benefits of alternative protein sources and the challenges associated with their production.

August 20, 2024

FDA approves new indication for Ardelyx’s tenapanor for serum phosphorus control

Nearly a year after successfully appealing a complete response letter, Ardelyx won FDA approval on Tuesday for Xphozah (tenapanor) for the control of serum phosphorus

October 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.